NMIMC
Northwestern Mutual Investment Management Company’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Sell |
22,097
-72
| -0.3% | -$9.05K | 0.04% | 167 |
|
|
2025
Q1 | $2.45M | Sell |
22,169
-333
| -1% | -$36.8K | 0.04% | 180 |
|
|
2024
Q4 | $3.07M | Buy |
22,502
+99
| +0.4% | +$13.5K | 0.07% | 130 |
|
|
2024
Q3 | $2.58M | Sell |
22,403
-59
| -0.3% | -$6.8K | 0.06% | 170 |
|
|
2024
Q2 | $3.09M | Buy |
22,462
+267
| +1% | +$36.8K | 0.08% | 117 |
|
|
2024
Q1 | $3.06M | Buy |
22,195
+337
| +2% | +$46.5K | 0.08% | 123 |
|
|
2023
Q4 | $2.88M | Buy |
21,858
+200
| +0.9% | +$26.4K | 0.08% | 125 |
|
|
2023
Q3 | $2.44M | Sell |
21,658
-27
| -0.1% | -$3.04K | 0.07% | 127 |
|
|
2023
Q2 | $2.04M | Buy |
21,685
+256
| +1% | +$24.1K | 0.05% | 164 |
|
|
2023
Q1 | $2.17M | Buy |
21,429
+12,532
| +141% | +$1.27M | 0.06% | 137 |
|
|
2022
Q4 | $1.06M | Sell |
8,897
-4,915
| -36% | -$587K | 0.03% | 229 |
|
|
2022
Q3 | $1.47M | Sell |
13,812
-2,186
| -14% | -$232K | 0.04% | 182 |
|
|
2022
Q2 | $1.56M | Buy |
15,998
+242
| +2% | +$23.6K | 0.04% | 211 |
|
|
2022
Q1 | $1.48M | Buy |
15,756
+30
| +0.2% | +$2.81K | 0.03% | 287 |
|
|
2021
Q4 | $1.34M | Buy |
15,726
+91
| +0.6% | +$7.75K | 0.03% | 383 |
|
|
2021
Q3 | $1.5M | Sell |
15,635
-111
| -0.7% | -$10.6K | 0.03% | 297 |
|
|
2021
Q2 | $1.53M | Buy |
15,746
+136
| +0.9% | +$13.2K | 0.03% | 290 |
|
|
2021
Q1 | $1.52M | Buy |
+15,610
| New | +$1.52M | 0.03% | 280 |
|